FB Care Service Co.,Ltd.
FB Care Service Co.,Ltd. (9220.T) Stock Competitors & Peer Comparison
See (9220.T) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 9220.T | ¥1,178.00 | +2.52% | 2.9B | 7.66 | ¥152.01 | +2.83% |
| 7071.T | ¥644.00 | +1.26% | 63.7B | 10.08 | ¥64.68 | +0.61% |
| 6099.T | ¥840.00 | +0.24% | 51.3B | 21.42 | ¥39.64 | +1.53% |
| 6197.T | ¥489.00 | +0.62% | 45.2B | 11.41 | ¥42.96 | +4.08% |
| 6062.T | ¥1,096.00 | -3.01% | 36.3B | 8.23 | ¥134.92 | +3.06% |
| 9158.T | ¥1,228.00 | +2.16% | 36.1B | 11.54 | ¥106.86 | N/A |
| 2372.T | ¥2,790.00 | +0.00% | 33.8B | 131.60 | ¥21.20 | N/A |
| 9229.T | ¥804.00 | +4.42% | 25.6B | -27.07 | -¥29.11 | +2.16% |
| 2374.T | ¥804.00 | +0.37% | 19.8B | 13.46 | ¥59.75 | +3.73% |
| 160A.T | ¥3,320.00 | -0.45% | 11.8B | 12.38 | ¥266.47 | +1.67% |
Stock Comparison
9220.T vs 7071.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 7071.T has a market cap of 63.7B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 7071.T trades at ¥644.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 7071.T's P/E ratio is 10.08. In terms of profitability, 9220.T's ROE is +0.11%, compared to 7071.T's ROE of +0.22%. Regarding short-term risk, 9220.T is less volatile compared to 7071.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9220.T.Check 7071.T's competition here
9220.T vs 6099.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 6099.T has a market cap of 51.3B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 6099.T trades at ¥840.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 6099.T's P/E ratio is 21.42. In terms of profitability, 9220.T's ROE is +0.11%, compared to 6099.T's ROE of +0.20%. Regarding short-term risk, 9220.T is more volatile compared to 6099.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9220.T.Check 6099.T's competition here
9220.T vs 6197.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 6197.T has a market cap of 45.2B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 6197.T trades at ¥489.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 6197.T's P/E ratio is 11.41. In terms of profitability, 9220.T's ROE is +0.11%, compared to 6197.T's ROE of +0.18%. Regarding short-term risk, 9220.T is more volatile compared to 6197.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9220.T.Check 6197.T's competition here
9220.T vs 6062.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 6062.T has a market cap of 36.3B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 6062.T trades at ¥1,096.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 6062.T's P/E ratio is 8.23. In terms of profitability, 9220.T's ROE is +0.11%, compared to 6062.T's ROE of +0.23%. Regarding short-term risk, 9220.T is less volatile compared to 6062.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9220.T.Check 6062.T's competition here
9220.T vs 9158.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 9158.T has a market cap of 36.1B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 9158.T trades at ¥1,228.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 9158.T's P/E ratio is 11.54. In terms of profitability, 9220.T's ROE is +0.11%, compared to 9158.T's ROE of +0.11%. Regarding short-term risk, 9220.T is less volatile compared to 9158.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9220.T.Check 9158.T's competition here
9220.T vs 2372.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 2372.T has a market cap of 33.8B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 2372.T trades at ¥2,790.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 2372.T's P/E ratio is 131.60. In terms of profitability, 9220.T's ROE is +0.11%, compared to 2372.T's ROE of +0.06%. Regarding short-term risk, 9220.T is more volatile compared to 2372.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9220.T.Check 2372.T's competition here
9220.T vs 9229.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 9229.T has a market cap of 25.6B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 9229.T trades at ¥804.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 9229.T's P/E ratio is -27.07. In terms of profitability, 9220.T's ROE is +0.11%, compared to 9229.T's ROE of -0.10%. Regarding short-term risk, 9220.T is less volatile compared to 9229.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9220.T.Check 9229.T's competition here
9220.T vs 2374.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 2374.T has a market cap of 19.8B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 2374.T trades at ¥804.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 2374.T's P/E ratio is 13.46. In terms of profitability, 9220.T's ROE is +0.11%, compared to 2374.T's ROE of +0.09%. Regarding short-term risk, 9220.T is more volatile compared to 2374.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9220.T.Check 2374.T's competition here
9220.T vs 160A.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 160A.T has a market cap of 11.8B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 160A.T trades at ¥3,320.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 160A.T's P/E ratio is 12.38. In terms of profitability, 9220.T's ROE is +0.11%, compared to 160A.T's ROE of +0.25%. Regarding short-term risk, 9220.T is more volatile compared to 160A.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9220.T.Check 160A.T's competition here
9220.T vs 7061.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 7061.T has a market cap of 11B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 7061.T trades at ¥1,303.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 7061.T's P/E ratio is 20.60. In terms of profitability, 9220.T's ROE is +0.11%, compared to 7061.T's ROE of +0.16%. Regarding short-term risk, 9220.T is more volatile compared to 7061.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9220.T.Check 7061.T's competition here
9220.T vs 6557.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 6557.T has a market cap of 9.6B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 6557.T trades at ¥1,476.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 6557.T's P/E ratio is 22.61. In terms of profitability, 9220.T's ROE is +0.11%, compared to 6557.T's ROE of +0.17%. Regarding short-term risk, 9220.T is more volatile compared to 6557.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9220.T.Check 6557.T's competition here
9220.T vs 8769.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 8769.T has a market cap of 9.4B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 8769.T trades at ¥594.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 8769.T's P/E ratio is 12.96. In terms of profitability, 9220.T's ROE is +0.11%, compared to 8769.T's ROE of +0.21%. Regarding short-term risk, 9220.T is more volatile compared to 8769.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9220.T.Check 8769.T's competition here
9220.T vs 7133.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 7133.T has a market cap of 9B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 7133.T trades at ¥1,278.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 7133.T's P/E ratio is 12.95. In terms of profitability, 9220.T's ROE is +0.11%, compared to 7133.T's ROE of +0.36%. Regarding short-term risk, 9220.T is more volatile compared to 7133.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9220.T.Check 7133.T's competition here
9220.T vs 194A.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 194A.T has a market cap of 6.9B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 194A.T trades at ¥938.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 194A.T's P/E ratio is 12.59. In terms of profitability, 9220.T's ROE is +0.11%, compared to 194A.T's ROE of +0.24%. Regarding short-term risk, 9220.T is less volatile compared to 194A.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9220.T.Check 194A.T's competition here
9220.T vs 6059.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 6059.T has a market cap of 6.5B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 6059.T trades at ¥329.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 6059.T's P/E ratio is 3.15. In terms of profitability, 9220.T's ROE is +0.11%, compared to 6059.T's ROE of +0.16%. Regarding short-term risk, 9220.T is more volatile compared to 6059.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9220.T.Check 6059.T's competition here
9220.T vs 2373.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 2373.T has a market cap of 5.6B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 2373.T trades at ¥412.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 2373.T's P/E ratio is 7.77. In terms of profitability, 9220.T's ROE is +0.11%, compared to 2373.T's ROE of +0.09%. Regarding short-term risk, 9220.T is more volatile compared to 2373.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9220.T.Check 2373.T's competition here
9220.T vs 7091.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 7091.T has a market cap of 4.3B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 7091.T trades at ¥950.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 7091.T's P/E ratio is 11.64. In terms of profitability, 9220.T's ROE is +0.11%, compared to 7091.T's ROE of +0.20%. Regarding short-term risk, 9220.T is more volatile compared to 7091.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9220.T.Check 7091.T's competition here
9220.T vs 7129.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 7129.T has a market cap of 3.2B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 7129.T trades at ¥1,142.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 7129.T's P/E ratio is 10.07. In terms of profitability, 9220.T's ROE is +0.11%, compared to 7129.T's ROE of +0.08%. Regarding short-term risk, 9220.T is more volatile compared to 7129.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9220.T.Check 7129.T's competition here
9220.T vs 2425.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 2425.T has a market cap of 3B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 2425.T trades at ¥801.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 2425.T's P/E ratio is 8.13. In terms of profitability, 9220.T's ROE is +0.11%, compared to 2425.T's ROE of +0.13%. Regarding short-term risk, 9220.T is more volatile compared to 2425.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9220.T.Check 2425.T's competition here
9220.T vs 2435.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 2435.T has a market cap of 2.6B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 2435.T trades at ¥228.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 2435.T's P/E ratio is 5.78. In terms of profitability, 9220.T's ROE is +0.11%, compared to 2435.T's ROE of +0.27%. Regarding short-term risk, 9220.T is more volatile compared to 2435.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9220.T.Check 2435.T's competition here
9220.T vs 6029.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 6029.T has a market cap of 2.5B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 6029.T trades at ¥251.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 6029.T's P/E ratio is 17.82. In terms of profitability, 9220.T's ROE is +0.11%, compared to 6029.T's ROE of -0.02%. Regarding short-term risk, 9220.T is less volatile compared to 6029.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9220.T.Check 6029.T's competition here
9220.T vs 7037.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 7037.T has a market cap of 2.5B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 7037.T trades at ¥548.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 7037.T's P/E ratio is -9.08. In terms of profitability, 9220.T's ROE is +0.11%, compared to 7037.T's ROE of -0.22%. Regarding short-term risk, 9220.T is more volatile compared to 7037.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9220.T.Check 7037.T's competition here
9220.T vs 9214.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 9214.T has a market cap of 2.2B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 9214.T trades at ¥1,575.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 9214.T's P/E ratio is 15.36. In terms of profitability, 9220.T's ROE is +0.11%, compared to 9214.T's ROE of +0.23%. Regarding short-term risk, 9220.T is more volatile compared to 9214.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9220.T.Check 9214.T's competition here
9220.T vs 7363.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 7363.T has a market cap of 1.5B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 7363.T trades at ¥1,694.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 7363.T's P/E ratio is 30.35. In terms of profitability, 9220.T's ROE is +0.11%, compared to 7363.T's ROE of +0.07%. Regarding short-term risk, 9220.T is more volatile compared to 7363.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9220.T.Check 7363.T's competition here
9220.T vs 7362.T Comparison August 2025
9220.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9220.T stands at 2.9B. In comparison, 7362.T has a market cap of 1.3B. Regarding current trading prices, 9220.T is priced at ¥1,178.00, while 7362.T trades at ¥841.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9220.T currently has a P/E ratio of 7.66, whereas 7362.T's P/E ratio is 11.30. In terms of profitability, 9220.T's ROE is +0.11%, compared to 7362.T's ROE of +0.07%. Regarding short-term risk, 9220.T is more volatile compared to 7362.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9220.T.Check 7362.T's competition here